Back to search
Primary Acquired Nasolacrimal Duct Obstruction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Acquired Nasolacrimal Duct Obstruction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Acquired Nasolacrimal Duct Obstruction trials you may qualify forPrimary acquired nasolacrimal duct obstruction
Primary acquired nasolacrimal duct obstruction (PANDO) is a lacrimal duct obstruction disease characterized by inflammatory fibrosis of the nasolacrimal duct, w…
All patients with epiphora or eye discharge that admitted to our ophthalmic plastic clinic in Farabi hospital will be systemically evaluated. Those with confirm…
While external DCR is the gold standard procedure for primary NLDO as well as complicated cases, SI with MMC could achieve comparable success rates in primary a…